Eyes That Do Not Meet the Eligibility Criteria of Clinical Trials on Age-Related Macular Degeneration: Proportion of the Real-World Patient Population and Reasons for Exclusion

CompletedOBSERVATIONAL
Enrollment

512

Participants

Timeline

Start Date

August 26, 2019

Primary Completion Date

January 26, 2020

Study Completion Date

July 26, 2020

Conditions
Age-related Macular Degeneration
Interventions
DRUG

Intravitreal anti-vascular endothelial growth factor injection

Intravitreal injection of either ranibizumab or aflibercept

Trial Locations (1)

150-034

Jae Hui Kim, Seoul

All Listed Sponsors
lead

Kim's Eye Hospital

OTHER

NCT04836143 - Eyes That Do Not Meet the Eligibility Criteria of Clinical Trials on Age-Related Macular Degeneration: Proportion of the Real-World Patient Population and Reasons for Exclusion | Biotech Hunter | Biotech Hunter